Abstract

ObjectiveTo assess the economic impact of introducing biosimilars of bevacizumab for the management of cancer patients receiving systemic bevacizumab in the National Health System (SNHS) of Spain.MethodsA 3-year budget impact...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Biosimilars in supportive care.
Emma Foreman
Current opinion in oncology | VOL. 32
Emma ForemanEmma Foreman
13 May 2020
Rapid diagnostic test for G6PD deficiency in Plasmodium vivax-infected men: a budget impact analysis based in Brazilian Amazon.
Henry Maia Peixoto ... Maria Regina Fernandes De Oliveira
Tropical Medicine and International Health | VOL. 22
Henry Maia Peixoto, et. al.Henry Maia Peixoto ... Maria Regina Fernandes De Oliveira
14 Nov 2016
PCN113 COST-MINIMISATION AND FIVE-YEAR BUDGET IMPACT ANALYSIS FOR MVASI® (BEVACIZUMAB BIOSIMILAR) IN ITALY
N Despiégel ... I Gaikwad
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 22
N Despiégel, et. al.N Despiégel ... I Gaikwad
01 Nov 2019
Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain.
L Sabatelli ... G Crater
Journal of Investigational Allergology and Clinical Immunology | VOL. 27
L Sabatelli, et. al.L Sabatelli ... G Crater
10 Apr 2017
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia
Emine Ecem Kilinc ... Murat Akova
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Emine Ecem Kilinc, et. al.Emine Ecem Kilinc ... Murat Akova
24 Jul 2024
Cleaning validation for blister packaging machines in hospital-supplying pharmacies
Dominic Fenske ... Stephanie Zergiebel
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Dominic Fenske, et. al.Dominic Fenske ... Stephanie Zergiebel
23 Jul 2024
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports
Lorene Lipszyc ... Samy Babai
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Lorene Lipszyc, et. al.Lorene Lipszyc ... Samy Babai
22 Jul 2024
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
Patricia M L A Van Den Bemt ... Liset Van Dijk
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Patricia M L A Van Den Bemt, et. al.Patricia M L A Van Den Bemt ... Liset Van Dijk
17 Jul 2024
View more papers